RxDoctor Payments Data

Denise Cusick

Family · Succasunna, NJNPI 1356894414

Payments from drug & device makers

$1,364in general payments, 2019–2025

Across 79 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$223
  • Otsuka America Pharmaceutical, Inc.$112
  • Bayer$107
  • Corcept Therapeutics$104
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$81
  • Lilly USA, LLC$80
  • plus $657 from 20 others

What the payments were for

  • Food & beverage$1,364100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,364 in reported general payments places this provider in the 80th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban240$111,136
NuplazidPimavanserin Tartrate22$58,073
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$28,404
MyrbetriqMirabegron64$27,918
FarxigaDapagliflozin Propanediol48$26,624
JardianceEmpagliflozin32$24,251
XareltoRivaroxaban32$18,645
MounjaroTirzepatide11$18,202
TradjentaLinagliptin29$16,300
JanuviaSitagliptin Phosphate24$13,592
RexultiBrexpiprazole12$11,658
Breo ElliptaFluticasone/Vilanterol15$8,871
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc73$7,584
Atorvastatin Calcium332$4,901
Memantine Hcl104$4,687

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$111,136240 claims
GSKTrelegy Ellipta, Breo Ellipta$52$37,27645 claims
AstraZenecaFarxiga$223$26,62448 claims
Johnson & JohnsonXarelto$33$18,64532 claims
Lilly USA, LLCMounjaro$80$18,20211 claims
Otsuka America Pharmaceutical, Inc.Rexulti$112$11,65812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,692 family providers in New Jersey.

Other family in Succasunna

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →